The global market for Intravenous Sedatives was valued at US$ 627 million in the year 2024 and is projected to reach a revised size of US$ 955 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Intravenous Sedatives Market

A sedative is a drug that works by suppressing the central nervous system.

North American market for Intravenous Sedatives is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intravenous Sedatives is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Intravenous Sedatives include Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Sedatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Sedatives.

The Intravenous Sedatives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Sedatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous Sedatives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous Sedatives Market Report

Report Metric	Details
Report Name	Intravenous Sedatives Market
Accounted market size in year	US$ 627 million
Forecasted market size in 2031	US$ 955 million
CAGR	6.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Diazepam Midazolam Propofol Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan, Humanwell
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Sedatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Sedatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Intravenous Sedatives Market growing?

Ans: The Intravenous Sedatives Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Intravenous Sedatives Market size in 2031?

Ans: The Intravenous Sedatives Market size in 2031 will be US$ 955 million.

Who are the main players in the Intravenous Sedatives Market report?

Ans: The main players in the Intravenous Sedatives Market are Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan, Humanwell

What are the Application segmentation covered in the Intravenous Sedatives Market report?

Ans: The Applications covered in the Intravenous Sedatives Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Intravenous Sedatives Market report?

Ans: The Types covered in the Intravenous Sedatives Market report are Diazepam, Midazolam, Propofol, Other

1 Intravenous Sedatives Market Overview

1.1 Product Definition

1.2 Intravenous Sedatives by Type

1.2.1 Global Intravenous Sedatives Market Value Comparison by Type (2024 VS 2031)

1.2.2 Diazepam

1.2.3 Midazolam

1.2.4 Propofol

1.2.5 Other

1.3 Intravenous Sedatives by Application

1.3.1 Global Intravenous Sedatives Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Intravenous Sedatives Market Size Estimates and Forecasts

1.4.1 Global Intravenous Sedatives Revenue 2020-2031

1.4.2 Global Intravenous Sedatives Sales 2020-2031

1.4.3 Global Intravenous Sedatives Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Intravenous Sedatives Market Competition by Manufacturers

2.1 Global Intravenous Sedatives Sales Market Share by Manufacturers (2020-2025)

2.2 Global Intravenous Sedatives Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Intravenous Sedatives Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Intravenous Sedatives, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Intravenous Sedatives, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Intravenous Sedatives, Product Type & Application

2.7 Global Key Manufacturers of Intravenous Sedatives, Date of Enter into This Industry

2.8 Global Intravenous Sedatives Market Competitive Situation and Trends

2.8.1 Global Intravenous Sedatives Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Intravenous Sedatives Players Market Share by Revenue

2.8.3 Global Intravenous Sedatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Intravenous Sedatives Market Scenario by Region

3.1 Global Intravenous Sedatives Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Intravenous Sedatives Sales by Region: 2020-2031

3.2.1 Global Intravenous Sedatives Sales by Region: 2020-2025

3.2.2 Global Intravenous Sedatives Sales by Region: 2026-2031

3.3 Global Intravenous Sedatives Revenue by Region: 2020-2031

3.3.1 Global Intravenous Sedatives Revenue by Region: 2020-2025

3.3.2 Global Intravenous Sedatives Revenue by Region: 2026-2031

3.4 North America Intravenous Sedatives Market Facts & Figures by Country

3.4.1 North America Intravenous Sedatives Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Intravenous Sedatives Sales by Country (2020-2031)

3.4.3 North America Intravenous Sedatives Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Intravenous Sedatives Market Facts & Figures by Country

3.5.1 Europe Intravenous Sedatives Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Intravenous Sedatives Sales by Country (2020-2031)

3.5.3 Europe Intravenous Sedatives Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Intravenous Sedatives Market Facts & Figures by Region

3.6.1 Asia Pacific Intravenous Sedatives Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Intravenous Sedatives Sales by Region (2020-2031)

3.6.3 Asia Pacific Intravenous Sedatives Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Intravenous Sedatives Market Facts & Figures by Country

3.7.1 Latin America Intravenous Sedatives Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Intravenous Sedatives Sales by Country (2020-2031)

3.7.3 Latin America Intravenous Sedatives Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Intravenous Sedatives Market Facts & Figures by Country

3.8.1 Middle East and Africa Intravenous Sedatives Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Intravenous Sedatives Sales by Country (2020-2031)

3.8.3 Middle East and Africa Intravenous Sedatives Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Intravenous Sedatives Sales by Type (2020-2031)

4.1.1 Global Intravenous Sedatives Sales by Type (2020-2025)

4.1.2 Global Intravenous Sedatives Sales by Type (2026-2031)

4.1.3 Global Intravenous Sedatives Sales Market Share by Type (2020-2031)

4.2 Global Intravenous Sedatives Revenue by Type (2020-2031)

4.2.1 Global Intravenous Sedatives Revenue by Type (2020-2025)

4.2.2 Global Intravenous Sedatives Revenue by Type (2026-2031)

4.2.3 Global Intravenous Sedatives Revenue Market Share by Type (2020-2031)

4.3 Global Intravenous Sedatives Price by Type (2020-2031)

5 Segment by Application

5.1 Global Intravenous Sedatives Sales by Application (2020-2031)

5.1.1 Global Intravenous Sedatives Sales by Application (2020-2025)

5.1.2 Global Intravenous Sedatives Sales by Application (2026-2031)

5.1.3 Global Intravenous Sedatives Sales Market Share by Application (2020-2031)

5.2 Global Intravenous Sedatives Revenue by Application (2020-2031)

5.2.1 Global Intravenous Sedatives Revenue by Application (2020-2025)

5.2.2 Global Intravenous Sedatives Revenue by Application (2026-2031)

5.2.3 Global Intravenous Sedatives Revenue Market Share by Application (2020-2031)

5.3 Global Intravenous Sedatives Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Astrazeneca

6.1.1 Astrazeneca Company Information

6.1.2 Astrazeneca Description and Business Overview

6.1.3 Astrazeneca Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Astrazeneca Intravenous Sedatives Product Portfolio

6.1.5 Astrazeneca Recent Developments/Updates

6.2 Fresenius-Kabi

6.2.1 Fresenius-Kabi Company Information

6.2.2 Fresenius-Kabi Description and Business Overview

6.2.3 Fresenius-Kabi Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Fresenius-Kabi Intravenous Sedatives Product Portfolio

6.2.5 Fresenius-Kabi Recent Developments/Updates

6.3 AbbVie

6.3.1 AbbVie Company Information

6.3.2 AbbVie Description and Business Overview

6.3.3 AbbVie Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AbbVie Intravenous Sedatives Product Portfolio

6.3.5 AbbVie Recent Developments/Updates

6.4 Baxter Healthcare

6.4.1 Baxter Healthcare Company Information

6.4.2 Baxter Healthcare Description and Business Overview

6.4.3 Baxter Healthcare Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Baxter Healthcare Intravenous Sedatives Product Portfolio

6.4.5 Baxter Healthcare Recent Developments/Updates

6.5 B.Braun

6.5.1 B.Braun Company Information

6.5.2 B.Braun Description and Business Overview

6.5.3 B.Braun Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.5.4 B.Braun Intravenous Sedatives Product Portfolio

6.5.5 B.Braun Recent Developments/Updates

6.6 Maruishi

6.6.1 Maruishi Company Information

6.6.2 Maruishi Description and Business Overview

6.6.3 Maruishi Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Maruishi Intravenous Sedatives Product Portfolio

6.6.5 Maruishi Recent Developments/Updates

6.7 Piramal

6.7.1 Piramal Company Information

6.7.2 Piramal Description and Business Overview

6.7.3 Piramal Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Piramal Intravenous Sedatives Product Portfolio

6.7.5 Piramal Recent Developments/Updates

6.8 Hikma Pharmaceuticals

6.8.1 Hikma Pharmaceuticals Company Information

6.8.2 Hikma Pharmaceuticals Description and Business Overview

6.8.3 Hikma Pharmaceuticals Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Hikma Pharmaceuticals Intravenous Sedatives Product Portfolio

6.8.5 Hikma Pharmaceuticals Recent Developments/Updates

6.9 Mylan

6.9.1 Mylan Company Information

6.9.2 Mylan Description and Business Overview

6.9.3 Mylan Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Mylan Intravenous Sedatives Product Portfolio

6.9.5 Mylan Recent Developments/Updates

6.10 Nhwa

6.10.1 Nhwa Company Information

6.10.2 Nhwa Description and Business Overview

6.10.3 Nhwa Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Nhwa Intravenous Sedatives Product Portfolio

6.10.5 Nhwa Recent Developments/Updates

6.11 Hengrui

6.11.1 Hengrui Company Information

6.11.2 Hengrui Description and Business Overview

6.11.3 Hengrui Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hengrui Intravenous Sedatives Product Portfolio

6.11.5 Hengrui Recent Developments/Updates

6.12 Lunan

6.12.1 Lunan Company Information

6.12.2 Lunan Description and Business Overview

6.12.3 Lunan Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Lunan Intravenous Sedatives Product Portfolio

6.12.5 Lunan Recent Developments/Updates

6.13 Humanwell

6.13.1 Humanwell Company Information

6.13.2 Humanwell Description and Business Overview

6.13.3 Humanwell Intravenous Sedatives Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Humanwell Intravenous Sedatives Product Portfolio

6.13.5 Humanwell Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Intravenous Sedatives Industry Chain Analysis

7.2 Intravenous Sedatives Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Intravenous Sedatives Production Mode & Process Analysis

7.4 Intravenous Sedatives Sales and Marketing

7.4.1 Intravenous Sedatives Sales Channels

7.4.2 Intravenous Sedatives Distributors

7.5 Intravenous Sedatives Customer Analysis

8 Intravenous Sedatives Market Dynamics

8.1 Intravenous Sedatives Industry Trends

8.2 Intravenous Sedatives Market Drivers

8.3 Intravenous Sedatives Market Challenges

8.4 Intravenous Sedatives Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Hikma Pharmaceuticals

List of Tables

Table 1. Global Intravenous Sedatives Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Intravenous Sedatives Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Intravenous Sedatives Market Competitive Situation by Manufacturers in 2024

Table 4. Global Intravenous Sedatives Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Intravenous Sedatives Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Intravenous Sedatives Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Intravenous Sedatives Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Intravenous Sedatives Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Intravenous Sedatives, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Intravenous Sedatives, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Intravenous Sedatives, Product Type & Application

Table 12. Global Key Manufacturers of Intravenous Sedatives, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Intravenous Sedatives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Sedatives as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Intravenous Sedatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Intravenous Sedatives Sales by Region (2020-2025) & (K Units)

Table 18. Global Intravenous Sedatives Sales Market Share by Region (2020-2025)

Table 19. Global Intravenous Sedatives Sales by Region (2026-2031) & (K Units)

Table 20. Global Intravenous Sedatives Sales Market Share by Region (2026-2031)

Table 21. Global Intravenous Sedatives Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Intravenous Sedatives Revenue Market Share by Region (2020-2025)

Table 23. Global Intravenous Sedatives Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Intravenous Sedatives Revenue Market Share by Region (2026-2031)

Table 25. North America Intravenous Sedatives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Intravenous Sedatives Sales by Country (2020-2025) & (K Units)

Table 27. North America Intravenous Sedatives Sales by Country (2026-2031) & (K Units)

Table 28. North America Intravenous Sedatives Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Intravenous Sedatives Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Intravenous Sedatives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Intravenous Sedatives Sales by Country (2020-2025) & (K Units)

Table 32. Europe Intravenous Sedatives Sales by Country (2026-2031) & (K Units)

Table 33. Europe Intravenous Sedatives Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Intravenous Sedatives Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Intravenous Sedatives Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Intravenous Sedatives Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Intravenous Sedatives Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Intravenous Sedatives Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Intravenous Sedatives Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Intravenous Sedatives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Intravenous Sedatives Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Intravenous Sedatives Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Intravenous Sedatives Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Intravenous Sedatives Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Intravenous Sedatives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Intravenous Sedatives Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Intravenous Sedatives Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Intravenous Sedatives Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Intravenous Sedatives Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Intravenous Sedatives Sales (K Units) by Type (2020-2025)

Table 51. Global Intravenous Sedatives Sales (K Units) by Type (2026-2031)

Table 52. Global Intravenous Sedatives Sales Market Share by Type (2020-2025)

Table 53. Global Intravenous Sedatives Sales Market Share by Type (2026-2031)

Table 54. Global Intravenous Sedatives Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Intravenous Sedatives Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Intravenous Sedatives Revenue Market Share by Type (2020-2025)

Table 57. Global Intravenous Sedatives Revenue Market Share by Type (2026-2031)

Table 58. Global Intravenous Sedatives Price (US$/Unit) by Type (2020-2025)

Table 59. Global Intravenous Sedatives Price (US$/Unit) by Type (2026-2031)

Table 60. Global Intravenous Sedatives Sales (K Units) by Application (2020-2025)

Table 61. Global Intravenous Sedatives Sales (K Units) by Application (2026-2031)

Table 62. Global Intravenous Sedatives Sales Market Share by Application (2020-2025)

Table 63. Global Intravenous Sedatives Sales Market Share by Application (2026-2031)

Table 64. Global Intravenous Sedatives Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Intravenous Sedatives Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Intravenous Sedatives Revenue Market Share by Application (2020-2025)

Table 67. Global Intravenous Sedatives Revenue Market Share by Application (2026-2031)

Table 68. Global Intravenous Sedatives Price (US$/Unit) by Application (2020-2025)

Table 69. Global Intravenous Sedatives Price (US$/Unit) by Application (2026-2031)

Table 70. Astrazeneca Company Information

Table 71. Astrazeneca Description and Business Overview

Table 72. Astrazeneca Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Astrazeneca Intravenous Sedatives Product

Table 74. Astrazeneca Recent Developments/Updates

Table 75. Fresenius-Kabi Company Information

Table 76. Fresenius-Kabi Description and Business Overview

Table 77. Fresenius-Kabi Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Fresenius-Kabi Intravenous Sedatives Product

Table 79. Fresenius-Kabi Recent Developments/Updates

Table 80. AbbVie Company Information

Table 81. AbbVie Description and Business Overview

Table 82. AbbVie Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. AbbVie Intravenous Sedatives Product

Table 84. AbbVie Recent Developments/Updates

Table 85. Baxter Healthcare Company Information

Table 86. Baxter Healthcare Description and Business Overview

Table 87. Baxter Healthcare Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Baxter Healthcare Intravenous Sedatives Product

Table 89. Baxter Healthcare Recent Developments/Updates

Table 90. B.Braun Company Information

Table 91. B.Braun Description and Business Overview

Table 92. B.Braun Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. B.Braun Intravenous Sedatives Product

Table 94. B.Braun Recent Developments/Updates

Table 95. Maruishi Company Information

Table 96. Maruishi Description and Business Overview

Table 97. Maruishi Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Maruishi Intravenous Sedatives Product

Table 99. Maruishi Recent Developments/Updates

Table 100. Piramal Company Information

Table 101. Piramal Description and Business Overview

Table 102. Piramal Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Piramal Intravenous Sedatives Product

Table 104. Piramal Recent Developments/Updates

Table 105. Hikma Pharmaceuticals Company Information

Table 106. Hikma Pharmaceuticals Description and Business Overview

Table 107. Hikma Pharmaceuticals Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Hikma Pharmaceuticals Intravenous Sedatives Product

Table 109. Hikma Pharmaceuticals Recent Developments/Updates

Table 110. Mylan Company Information

Table 111. Mylan Description and Business Overview

Table 112. Mylan Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Mylan Intravenous Sedatives Product

Table 114. Mylan Recent Developments/Updates

Table 115. Nhwa Company Information

Table 116. Nhwa Description and Business Overview

Table 117. Nhwa Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Nhwa Intravenous Sedatives Product

Table 119. Nhwa Recent Developments/Updates

Table 120. Hengrui Company Information

Table 121. Hengrui Description and Business Overview

Table 122. Hengrui Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Hengrui Intravenous Sedatives Product

Table 124. Hengrui Recent Developments/Updates

Table 125. Lunan Company Information

Table 126. Lunan Description and Business Overview

Table 127. Lunan Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Lunan Intravenous Sedatives Product

Table 129. Lunan Recent Developments/Updates

Table 130. Humanwell Company Information

Table 131. Humanwell Description and Business Overview

Table 132. Humanwell Intravenous Sedatives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Humanwell Intravenous Sedatives Product

Table 134. Humanwell Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Intravenous Sedatives Distributors List

Table 138. Intravenous Sedatives Customers List

Table 139. Intravenous Sedatives Market Trends

Table 140. Intravenous Sedatives Market Drivers

Table 141. Intravenous Sedatives Market Challenges

Table 142. Intravenous Sedatives Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Intravenous Sedatives

Figure 2. Global Intravenous Sedatives Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Intravenous Sedatives Market Share by Type: 2024 & 2031

Figure 4. Diazepam Product Picture

Figure 5. Midazolam Product Picture

Figure 6. Propofol Product Picture

Figure 7. Other Product Picture

Figure 8. Global Intravenous Sedatives Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Intravenous Sedatives Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Other

Figure 13. Global Intravenous Sedatives Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Intravenous Sedatives Market Size (2020-2031) & (US$ Million)

Figure 15. Global Intravenous Sedatives Sales (2020-2031) & (K Units)

Figure 16. Global Intravenous Sedatives Average Price (US$/Unit) & (2020-2031)

Figure 17. Intravenous Sedatives Report Years Considered

Figure 18. Intravenous Sedatives Sales Share by Manufacturers in 2024

Figure 19. Global Intravenous Sedatives Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Intravenous Sedatives Players: Market Share by Revenue in Intravenous Sedatives in 2024

Figure 21. Intravenous Sedatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Intravenous Sedatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Intravenous Sedatives Sales Market Share by Country (2020-2031)

Figure 24. North America Intravenous Sedatives Revenue Market Share by Country (2020-2031)

Figure 25. United States Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Intravenous Sedatives Sales Market Share by Country (2020-2031)

Figure 28. Europe Intravenous Sedatives Revenue Market Share by Country (2020-2031)

Figure 29. Germany Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Intravenous Sedatives Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Intravenous Sedatives Revenue Market Share by Region (2020-2031)

Figure 36. China Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Intravenous Sedatives Sales Market Share by Country (2020-2031)

Figure 44. Latin America Intravenous Sedatives Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Intravenous Sedatives Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Intravenous Sedatives Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Intravenous Sedatives Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Intravenous Sedatives by Type (2020-2031)

Figure 54. Global Revenue Market Share of Intravenous Sedatives by Type (2020-2031)

Figure 55. Global Intravenous Sedatives Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Intravenous Sedatives by Application (2020-2031)

Figure 57. Global Revenue Market Share of Intravenous Sedatives by Application (2020-2031)

Figure 58. Global Intravenous Sedatives Price (US$/Unit) by Application (2020-2031)

Figure 59. Intravenous Sedatives Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Intravenous Sedatives Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-22R14780

Global Intravenous Sedatives Market Research Report 2025

FEATURED COMPANIES

Intravenous Sedatives Market Size

Intravenous Sedatives Market

Report Scope

Scope of Intravenous Sedatives Market Report

Core Chapters

FAQ for this report

How fast is Intravenous Sedatives Market growing?

What is the Intravenous Sedatives Market size in 2031?

Who are the main players in the Intravenous Sedatives Market report?

What are the Application segmentation covered in the Intravenous Sedatives Market report?

What are the Type segmentation covered in the Intravenous Sedatives Market report?

FEATURED COMPANIES

RELATED REPORTS